---
title: Small Molecule CROs in Canada
path: /modalities/small-molecule/canada
companies_count: 15
---

# Small Molecule CROs in Canada

15 published CROs match Small Molecule in Canada.

Locations in this set include Canada, United States, United Kingdom, Australia, France, and Germany.

Capabilities that show up most often in this set: Regulatory Affairs, Clinical Operations, Phase I Clinical Trials, Phase II Clinical Trials, and Data Management & eClinical.

## Matching companies

- [ARSI Canada Inc](/companies/arsicanada)
  - ARSI Canada is a specialized CRO offering custom synthesis, API scale-up, analytical method development, and drug development services with over 50 years of combined experience and a GMP manufacturing facility in Bangladesh.
- [Altasciences](/companies/altasciences)
  - Mid-size early phase CRO/CDMO in Canada and the U.S. offering preclinical safety testing, clinical pharmacology (Phase I–II), bioanalysis, research services, and manufacturing with integrated capabilities.
- [Applied Pharmaceutical Innovation](/companies/appliedpharma)
  - Edmonton-based not-for-profit offering integrated CDMO services in sterile fill-finish, oral solid dosage, topical application, and highly potent controlled substance manufacturing. Also provides CRO research, regulatory and quality, and clinical and quantitative support.
- [BioPharma Services Inc.](/companies/biopharmaservices)
  - Full-service Phase 1 CRO specializing in early-stage clinical trials, bioequivalence/bioavailability studies, and human abuse potential assessments with state-of-the-art facilities in Toronto and in-house bioanalytical labs.
- [CanAm Bioresearch Inc.](/companies/canambioresearch)
  - Medicinal chemistry CRO offering drug discovery, custom organic synthesis, and analytical chemistry services with an all-Ph.D. team and 25+ years of experience.
- [Celerion](/companies/celerion)
  - Global CRO specializing in early-phase clinical research and bioanalytical sciences with 650+ beds across 30 countries and 50+ years of experience.
- [HAARES ChemTech Inc.](/companies/haareschemtech)
  - HAARES ChemTech provides custom synthesis and contract R&D for complex organic molecules from Edmonton, Canada. Its PhD-level chemists work from milligram to multi-kilogram scale, and the company also offers process development and intermediate manufacture.
- [ITR Laboratories](/companies/itrlab)
  - GLP-compliant nonclinical CRO specializing in safety and toxicology testing across in silico, in vitro, and in vivo modalities, with 35+ years of experience and nearly 6,000 completed studies.
- [Pharma Inventor](/companies/pharmainventor)
  - Vancouver-based preclinical drug discovery CRO offering medicinal chemistry, custom synthesis, LC-MS/MS bioanalysis, high-throughput screening and ADC development for pharma and biotech teams. Lists 6,000+ sq ft of research facilities and in-house 400 MHz NMR.
- [Premier Research](/companies/premier-research)
  - Premier Research is a global full-service CRO delivering clinical research and development solutions across the complete drug development lifecycle. The organization provides comprehensive capabilities spanning study design, study startup, medical affairs, biostatistics and data management, central monitoring, clinical monitoring and site management, project and risk management, safety and pharmacovigilance, quality and compliance, and medical writing.
- [ResolveMass Laboratories Inc.](/companies/resolvemass)
  - Canadian CRO and CDMO specializing in polymer synthesis, peptide characterization, and advanced analytical services for drug delivery and pharmaceutical development. FDA-registered and ISO 9001:2015 certified, serving North American pharmaceutical and biotech companies.
- [Sussex Research Laboratories Inc.](/companies/sussex-research)
  - Global leader in carbohydrate and glycan synthesis, offering custom synthesis, CRO, and CDMO services for drug discovery and development. Specializes in GalNAc targeting ligands, glycopeptides, and glycoconjugates with over 25 years of expertise.
- [Sygnature Discovery](/companies/sygnaturediscovery)
  - Integrated drug discovery CRO covering target identification through lead optimization, with computational design, structural biology, medicinal chemistry and DMPK support. Serves biotech and pharma clients across the US, Canada, UK and Europe.
- [Syneos Health](/companies/syneoshealth)
  - Global CRO with 26,000+ employees offering integrated clinical development, regulatory affairs, and commercialization services. Helped develop or commercialize 96% of FDA-approved oncology drugs and 93% of EMA-authorized oncology products in the last five years.
- [TFS HealthScience](/companies/tfscro)
  - Global mid-size CRO specializing in dermatology, internal medicine, neuroscience, oncology, and ophthalmology with Phase I-IV clinical development, real-world evidence studies, and flexible resourcing solutions across 600+ experts in Europe, North America, and Australia.